Secukinumab Reduces Psoriasis-associated Pruritus and Regenerates the Cutaneous Nerve Architecture: Results from PSORITUS a Doubleblind, Placebo-controlled, Randomized Withdrawal Phase IIIb Study

The occurrence of pruritus in psoriasis was previously underestimated but is a significant burden. Secukinumab (SEC), a monoclonal anti-interleukin-17A antibody, efficiently controls signs of psoriasis, but the effect on pruritus and cutaneous neuroanatomy remained unknown. The primary objective of...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Lina Renkhold, Manuel P. Pereira, Karin Loser, Dieter Metze, Daniel Baeumer, Nima Melzer, Maximilian Reinhardt, Athanasios Tsianakas, Thomas Luger, Christian Mess, Ruth Becker, Clara Hambüchen, Konstantin Agelopoulos, Sonja Ständer
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Medical Journals Sweden 2024-11-01
Serie:	Acta Dermato-Venereologica
Ämnen:	Pruritus Psoriasis Neuroanatomy Therapy
Länkar:	https://medicaljournalssweden.se/actadv/article/view/40737
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!